Related references
Note: Only part of the references are listed.Array CGH as a potential predictor of radiocurability in intermediate risk prostate cancer
Adrian S. Ishkanian et al.
ACTA ONCOLOGICA (2010)
THE EFFECTS OF G2-PHASE ENRICHMENT AND CHECKPOINT ABROGATION ON LOW-DOSE HYPER-RADIOSENSITIVITY
Sarah A. Krueger et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer
J. Nilsson et al.
BRITISH JOURNAL OF CANCER (2009)
TMPRSS2-ERG fusion is frequently observed in gleason pattern 3 prostate cancer in a canadian cohort
Andrew D. Darnel et al.
CANCER BIOLOGY & THERAPY (2009)
Predisposition for TMPRSS2-ERG Fusion in Prostate Cancer by Variants in DNA Repair Genes
Manuel Luedeke et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Induction of Prostatic Intraepithelial Neoplasia and Modulation of Androgen Receptor by ETS Variant 1/ETS-Related Protein 81
Sook Shin et al.
CANCER RESEARCH (2009)
Characterization of ETS gene aberrations in select histologic variants of prostate carcinoma
Bo Han et al.
MODERN PATHOLOGY (2009)
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate
Brett S. Carver et al.
NATURE GENETICS (2009)
Induced Chromosomal Proximity and Gene Fusions in Prostate Cancer
Ram-Shankar Mani et al.
SCIENCE (2009)
Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome
Maisa Yoshimoto et al.
MODERN PATHOLOGY (2008)
Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer
G. Attard et al.
ONCOGENE (2008)
TMPRSS2: ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort
F. Demichelis et al.
ONCOGENE (2007)
TMPRSS2-ERG fusion prostate cancer:: An early molecular event associated with invasion
Sven Perner et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
Nadir prostate-specific antigen within 12 months after radiotherapy predicts biochemical and distant failure
Michael E. Ray et al.
UROLOGY (2006)
TMPRSS2:: ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer
Sven Perner et al.
CANCER RESEARCH (2006)
Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer
Jianghua Wang et al.
CANCER RESEARCH (2006)
Phosphorylated histone H2AX in relation to cell survival in tumor cells and xenografts exposed to single and fractionated doses of X-rays
Dmitry Klokov et al.
RADIOTHERAPY AND ONCOLOGY (2006)
Confirmation of the high frequency of the TMPRSS2/ERG fusion gene in prostate cancer
Maria Johansson Soller et al.
GENES CHROMOSOMES & CANCER (2006)
Low-dose hyper-radiosensitivity is not caused by a failure to recognize DNA double-strand breaks
SM Wykes et al.
RADIATION RESEARCH (2006)
TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer
SA Tomlins et al.
CANCER RESEARCH (2006)
The prostatic specific antigen era is alive and well: Prostatic specific antigen and biochemical progression following radical prostatectomy
SJ Freedland et al.
JOURNAL OF UROLOGY (2005)
The two edges of the ATM sword:: Co-operation between repair and checkpoint functions
M Löbrich et al.
RADIOTHERAPY AND ONCOLOGY (2005)
Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome
G Petrovics et al.
ONCOGENE (2005)
Tumor development by transgenic expression of a constitutively active insulin-like growth factor I receptor
JM Carboni et al.
CANCER RESEARCH (2005)
Share Paper
